Follow the 원바이오젠 stock price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares trade on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 원바이오젠 has recorded 15 insider filings. The latest transaction was filed on 21 November 2024 (Sale). Among the most active insiders: 교보증권. All data is openly available.
15
Insider Decl.
n/a
Thresholds
n/a
3 ops.
Buy Volume
n/a
11 ops.
Sell Volume
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.